PhD Pharmaceutical Sciences
Analytical Development • Method Validation • GMP/GLP
Final-year PhD candidate at UCL School of Pharmacy with expertise in HPLC method development, formulation stability, and regulatory compliance (ICH Q2(R1)). Seeking roles in analytical R&D or quality control within the pharmaceutical industry.
Dedicated to advancing drug quality through rigorous analytical science
I am a final-year PhD candidate at UCL School of Pharmacy, specialising in analytical method development for complex biopharmaceutical formulations. My research focuses on stability-indicating HPLC and spectroscopic techniques for novel drug delivery systems.
Through my industrial placement at a leading CRO and my academic research, I have developed a thorough understanding of GMP/GLP environments, ICH guidelines, and the regulatory landscape governing pharmaceutical development. I am eager to contribute to a team committed to bringing safe, effective medicines to market.
Analytical Method Development & Validation
ICH Q2(R1), Q3D, Q1A; EU GMP Annex 1
HPLC, UPLC, UV-Vis, FTIR, DSC, Particle Size Analysis
English (Native), Mandarin (Fluent), German (Conversational)
Academic training in pharmaceutical and analytical sciences
Research placements and industry exposure
Analytical techniques and software competencies
Professional development and compliance training
EU GMP Annex 1 and PIC/S guidelines for sterile manufacturing and QC laboratories.
Feb 2025OECD principles of GLP, study planning, and QA for non-clinical laboratory studies.
Nov 2024Statistical experimental design for robust method development and formulation optimisation.
Jun 2024Chemical hazard management, risk assessment, and safe handling of potent compounds.
Sep 2023Selected academic and industry projects
Developed and fully validated a reverse-phase HPLC method capable of resolving the API, three known degradants, and excipient peaks. Demonstrated specificity, linearity (R² > 0.999), and robustness per ICH Q2(R1).
Conducted stress-testing (acid, base, oxidative, thermal, photolytic) on a model API. Identified and characterised major degradants using LC-MS and proposed degradation pathways.
Led a method transfer project migrating a legacy HPLC assay to UPLC. Optimised gradient and column chemistry to reduce run time by 60% while maintaining resolution criteria.
I am actively seeking analytical R&D, formulation development, and quality control roles within the pharmaceutical and biotech sectors. I would welcome the opportunity to discuss how my skills can contribute to your team.